EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 12-May-2025 19:09 ET (12-May-2025 23:09 GMT/UTC)

3-Feb-2025

CAR-T cells can arm bystander T cells with CAR molecules via trogocytosis

Uppsala University
Peer-Reviewed Publication

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR molecules can be transferred from the CAR-T cells to other T cells in the tumour microenvironment. The researchers also pinpoint how this transfer is regulated, which may be used to improve the efficacy of CAR-T cell therapy. The study has been published in the journal Science Immunology.

Journal: Science Immunology

3-Feb-2025

AI-supported breast cancer screening – new results suggest even higher accuracy

Lund University
Peer-Reviewed Publication

New research results now published from Lund University’s MASAI trial are even better than the initial findings from last year: AI-supported breast screening detected 29 per cent more cases of cancer compared with traditional screening. More invasive cancers were also clearly detected at an early stage using AI. Now the final part of the research study will focus on breast cancer missed by screening.

Journal: The Lancet Digital Health
Funder: Swedish Cancer Society, Lund University/ALF, Confederation of Regional Cancer Centres and MAS Cancer

2-Feb-2025

Could the contraceptive pill reduce risk of ovarian cancer?

University of South Australia
Peer-Reviewed Publication

It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or ‘the Pill’) could also help reduce the risk of ovarian cancer, according to new research from the University of South Australia.

Journal: International Journal of Gynecological Cancer
Funder: MRFF

31-Jan-2025

Millions mobilized on livestream game show to fight heart disease and save lives

American Heart Association
Business Announcement

20 top creators unite at TikTok headquarters in New York City to raise awareness for heart disease and funds for the American Heart Association to kick off Heart Month 2025

31-Jan-2025

New research unlocks key to long-lasting immune response in cancer and chronic diseases

University of Melbourne
Peer-Reviewed Publication

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders – T cells – lose their ability to function effectively. Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Centre (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.

Journal: Science Immunology
Funder: National Health and Medical Research Council, Cass Foundation, Cancer Council Victoria, Kids' Cancer Project, UK Research and Innovation, University of Melbourne, Clive and Vera Ramaciotti Foundation, J & M Wright Foundation, CSL

31-Jan-2025

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer Research, found that measuring the interaction between two proteins, RAS and RAF, could provide valuable insights into the effectiveness of treatments for patients with KRASG12C-mutant non-small cell lung cancer, a type of lung cancer known for being particularly difficult to treat.

Journal: Clinical Cancer Research
Funder: NIH/National Cancer Institute, NIH/National Cancer Institute, Revolution Medicines, H. Lee Moffitt Cancer Center and Research Institute

31-Jan-2025

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center.

Journal: The Lancet Oncology
Funder: NIH/National Institutes of Health, U.S. Department of Defense

31-Jan-2025

City of Hope scientists identify mechanism for self-repair of the thymus, a crucial component of the immune system

City of Hope
Peer-Reviewed Publication

City of Hope scientists identify a mechanism for self-repair of the thymus, a crucial component of the immune system, with research published in Immunity that could help boost thymic function after damage from cancer therapies and other factors

Journal: Immunity

31-Jan-2025

How UIC scientists redesigned an effective cancer therapy to make it safer

University of Illinois Chicago
Reports and Proceedings

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers.

31-Jan-2025

Anti-melanoma activity found in green-produced nanosilver-chlorhexidine complex

Pensoft Publishers
Peer-Reviewed Publication

A complex between green-synthesized silver nanoparticles and chlorhexidine has shown explicit anti-tumor activity against human melanoma. A trustful concentration range was established in which the active agent was effective against the cancer cells but remained non-toxic to the normal cells. The findings were published in the open-access journal Pharmacia.

Journal: Pharmacia